DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Food and Drug Administration (FDA).
Victoza (liraglutide [rDNA origin]) Injection: REMS – Risk of Thyroid C-cell Tumors, Acute Pancreatitis.
2011 [cited: 2013 Jul 04]. Available from:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258826.htm
Access:
We do not assume any responsibility for the contents of the web pages of other providers.